ReviewFrontiers in public health2025
Global burden and risk factors of childhood cardiovascular disease (1990-2021).
Review in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of growth markers and patterns of growth on children's cardiometabolic health: a life course perspective.World journal of pediatrics : WJP · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Childhood cardiovascular disease (CCVD) is a significant global health threat, with early risk factor accumulation potentially exerting profound impacts on cardiovascular health in adulthood. However, global data analyses on the burden of CCVD remain limited, particularly regarding variations across socio-demographic index (SDI) levels and effects of major risk factors. Objective: This study aimed to investigate worldwide patterns in the incidence and mortality of CCVD between 1990 and 2021 and examine how these trends vary by SDI, gender, age, and major environmental risk factors. Methods: This study analyzed the incidence, mortality, and estimated annual percentage change (EAPC) of CCVD in children aged 0 to 14 years during 1990-2021. Descriptive statistics, group comparisons, and correlation analyses were employed to evaluate the impact of SDI, gender, age, and environmental risks on the disease burden. Results: The global CCVD incidence rose from 1,486,136.37 cases (95% UI: 1,115,077.02-1,959,529.28) in 1990 to 1,861,693.20 cases (95% UI: 1,335,751.17-2,531,859.51) in 2021, an increase of approximately 25.27%, with an EAPC of 0.43 (95% UI: 0.35-0.51). Incidence rates increased continuously in low and low-middle SDI regions, whereas they showed a marked decline in regions with high and high-middle SDI levels. CCVD mortality decreased markedly in high-SDI regions but remained persistently high in low SDI regions. Gender and age analyses revealed higher incidence and mortality rates among female children compared to males, with the 10-14 age group being the most affected. Low temperatures were identified as a primary driver of CCVD burden, particularly in low-SDI regions. Conclusion: The global CCVD burden exhibits significant inequalities, largely driven by disparities in public health resource levels across regions with varying SDI. These findings highlight persistent global health inequalities and underscore the need for region-specific interventions, especially in low-SDI regions where the CCVD burden is rising.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.